Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolle J M Besselink

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Scientific Reports|February 14, 2019
Fibroblast growth factor receptor signaling in pediatric B-cell precursor acute lymphoblastic leukemiaIsabel S Jerchel, Alex Q Hoogkamer, Ingrid M Ariës, et al.
Anticancer Research|May 31, 2015
Effective Therapeutic Intervention and Comprehensive Genetic Analysis of mTOR Signaling in PEComa: A Case ReportFleur Weeber, Marco J Koudijs, Marlous Hoogstraat, et al.
Science (New York, N.Y.)|April 7, 2022
Genome-wide analysis of somatic noncoding mutation patterns in cancerFelix Dietlein, Alex B Wang, Christian Fagre, et al.
Breast Cancer Research : BCR|October 5, 2015
Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy responseEsther H Lips, Magali Michaut, Marlous Hoogstraat, et al.
The Journal of Molecular Diagnostics : JMD|December 3, 2014
Simultaneous detection of clinically relevant mutations and amplifications for routine cancer pathologyMarlous Hoogstraat, John W J Hinrichs, Nicolle J M Besselink, et al.
American Journal of Clinical Pathology|March 18, 2015
Comparison of next-generation sequencing and mutation-specific platforms in clinical practiceJohn W J Hinrichs, W T Marja van Blokland, Michiel J Moons, et al.
Oncotarget|November 23, 2017
<i>JAK2</i> aberrations in childhood B-cell precursor acute lymphoblastic leukemiaElisabeth M P Steeghs, Isabel S Jerchel, Willemieke de Goffau-Nobel, et al.
Pigment Cell & Melanoma Research|December 18, 2014
Detailed imaging and genetic analysis reveal a secondary BRAF(L505H) resistance mutation and extensive intrapatient heterogeneity in metastatic BRAF mutant melanoma patients treated with vemurafenibMarlous Hoogstraat, Christa G Gadellaa-van Hooijdonk, Inge Ubink, et al.
Cell Genomics|February 13, 2023
A multi-platform reference for somatic structural variation detectionJose Espejo Valle-Inclan, Nicolle J M Besselink, Ewart de Bruijn, et al.
Oncotarget|August 18, 2016
TP53 mutated glioblastoma stem-like cell cultures are sensitive to dual mTORC1/2 inhibition while resistance in TP53 wild type cultures can be overcome by combined inhibition of mTORC1/2 and Bcl-2Subramanian Venkatesan, Marlous Hoogstraat, Ester Caljouw, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Scientific Reports|February 14, 2019
Fibroblast growth factor receptor signaling in pediatric B-cell precursor acute lymphoblastic leukemiaIsabel S Jerchel, Alex Q Hoogkamer, Ingrid M Ariës, et al.
Anticancer Research|May 31, 2015
Effective Therapeutic Intervention and Comprehensive Genetic Analysis of mTOR Signaling in PEComa: A Case ReportFleur Weeber, Marco J Koudijs, Marlous Hoogstraat, et al.
Science (New York, N.Y.)|April 7, 2022
Genome-wide analysis of somatic noncoding mutation patterns in cancerFelix Dietlein, Alex B Wang, Christian Fagre, et al.
Breast Cancer Research : BCR|October 5, 2015
Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy responseEsther H Lips, Magali Michaut, Marlous Hoogstraat, et al.
The Journal of Molecular Diagnostics : JMD|December 3, 2014
Simultaneous detection of clinically relevant mutations and amplifications for routine cancer pathologyMarlous Hoogstraat, John W J Hinrichs, Nicolle J M Besselink, et al.
American Journal of Clinical Pathology|March 18, 2015
Comparison of next-generation sequencing and mutation-specific platforms in clinical practiceJohn W J Hinrichs, W T Marja van Blokland, Michiel J Moons, et al.
Oncotarget|November 23, 2017
<i>JAK2</i> aberrations in childhood B-cell precursor acute lymphoblastic leukemiaElisabeth M P Steeghs, Isabel S Jerchel, Willemieke de Goffau-Nobel, et al.
Pigment Cell & Melanoma Research|December 18, 2014
Detailed imaging and genetic analysis reveal a secondary BRAF(L505H) resistance mutation and extensive intrapatient heterogeneity in metastatic BRAF mutant melanoma patients treated with vemurafenibMarlous Hoogstraat, Christa G Gadellaa-van Hooijdonk, Inge Ubink, et al.
Cell Genomics|February 13, 2023
A multi-platform reference for somatic structural variation detectionJose Espejo Valle-Inclan, Nicolle J M Besselink, Ewart de Bruijn, et al.
Oncotarget|August 18, 2016
TP53 mutated glioblastoma stem-like cell cultures are sensitive to dual mTORC1/2 inhibition while resistance in TP53 wild type cultures can be overcome by combined inhibition of mTORC1/2 and Bcl-2Subramanian Venkatesan, Marlous Hoogstraat, Ester Caljouw, et al.
Pageof 2